Recurrent macular edema in central retinal vein occlusion treated with intravitreal ranibizumab using a modified treat and extend regimen

Klinische Monatsblatter fur Augenheilkunde

Volumn 232, Issue 4, 2015, Pages 538-541

  Dirani, A ^a   Mantel, I ^a   Ambresin, A ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

central retinal venous occlusion; intravitreal injection; macular edema; modified treat and extend regimen; ranibizumab

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR;

ADULT; ARTICLE; CASE STUDY; CENTRAL MACULAR THICKNESS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; LOADING DRUG DOSE; MACULAR EDEMA; MALE; PILOT STUDY; RECURRENT DISEASE; RETREATMENT; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT DURATION; VISUAL ACUITY; CASE REPORT; COMPLICATION; DRUG ADMINISTRATION; DRUG EFFECTS; INTRAVITREAL DRUG ADMINISTRATION; MACULAR DEGENERATION; MIDDLE AGED; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VISION DISORDERS;

ANGIOGENESIS INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RANIBIZUMAB; RECURRENCE; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY;

EID: 84928481233     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0035-1545746     Document Type: Article

References (7)

1. Campochiaro P. A., Hafiz G., Shah S. M. et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther: 2008; 16 791 799
2. Campochiaro P. A., Brown D. M., Awh C. C. et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology: 2011; 118 2041 2049
3. Heier J. S., Campochiaro P. A., Yau L. et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology: 2012; 119 802 809
4. Braithwaite T., Nanji A. A., Lindsley K. et al. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion. Cochrane Database Syst Rev: 2014; 5 CD007325
5. Campochiaro P. A., Sophie R., Pearlman J. et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN Study. Ophthalmology: 2014; 121 209 219
6. Campochiaro P. A., Bhistikul R. B., Shapiro H. et al. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology: 2013; 120 795 802
7. Singer M., Tan C. S., Bell D. et al. Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina: 2014; 34 1736 1742